Let's tie the knot: Marriage of complement and adaptive immunity in pathogen evasion, for better or worse

Frontiers in Microbiology

Volumn 8, Issue JAN, 2017, Pages

  Bennett, Kaila M ^a   Rooijakkers, Suzan H M ^a   Gorham, Ronald D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adaptive immunity; Antigen presenting cell; Complement receptors; Complement system; Crosstalk; Immune evasion

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; DECAY ACCELERATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; MEMBRANE COFACTOR PROTEIN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; NONHUMAN; PARACRINE SIGNALING; PATHOGEN CLEARANCE; PHAGOCYTOSIS; PRE T LYMPHOCYTE; REGULATORY MECHANISM; REVIEW;

EID: 85012016550     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00089     Document Type: Review

References (130)

1. Abdul-Aziz, M., Tsolaki, A. G., Kouser, L., Carroll, M. V., Al-Ahdal, M. N., Sim, R. B., et al. (2016). Complement factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine response. Immunobiology 221, 944-952. doi: 10.1016/j.imbio.2016.05.011
2. Arbore, G., West, E. E., Spolski, R., Robertson, A. A. B., Klos, A., Rheinheimer, C., et al. (2016). T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science 352, aad1210-aad1210. doi: 10.1126/science.aad1210
3. Avirutnan, P., Fuchs, A., Hauhart, R. E., Somnuke, P., Youn, S., Diamond, M. S., et al. (2010). Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207, 793-806. doi: 10.1084/jem.20092545
4. Avirutnan, P., Hauhart, R. E., Somnuke, P., Blom, A. M., Diamond, M. S., and Atkinson, J. P. (2011). Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187, 424-433. doi: 10.4049/jimmunol.1100750
5. Banerjee, A., Mazumdar, B., Meyer, K., Di Bisceglie, A. M., Ray, R. B., and Ray, R. (2011). Transcriptional repression of C4 complement by hepatitis C virus proteins. J. Virol. 85, 4157-4166. doi: 10.1128/JVI.02449-10
6. Banki, Z., Kacani, L., Rusert, P., Pruenster, M., Wilflingseder, D., Falkensammer, B., et al. (2005). Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS 19, 481-486. doi: 10.1097/01.aids.0000162336.20439.8d
7. Baruah, P., Dumitriu, I. E., Malik, T. H., Cook, H. T., Dyson, J., Scott, D., et al. (2009). C1q enhances IFN-γ production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 113, 3485-3493. doi: 10.1182/blood-2008-06-164392
8. Bergmann-Leitner, E. S., Leitner, W. W., and Tsokos, G. C. (2006). Complement 3d: from molecular adjuvant to target of immune escape mechanisms. Clin. Immunol. 121, 177-185. doi: 10.1016/j.clim.2006.07.001
9. Bergmann-Leitner, E. S., Scheiblhofer, S., Weiss, R., Duncan, E. H., Leitner, W. W., Chen, D., et al. (2005). C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int. Immunol. 17, 245-255. doi: 10.1093/intimm/dxh205
10. Blom, A. M., Villoutreix, B. O., and Dahlback, B. (2004). Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol. Immunol. 40, 1333-1346. doi: 10.1016/j.molimm.2003.12.002
11. Braun, L., Ghebrehiwet, B., and Cossart, P. (2000). gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 19, 1458-1466. doi: 10.1093/emboj/19.7.1458
12. Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K. P., and Mosser, D. M. (1995). Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155, 3102-3111.
13. Broadley, S. P., Plaumann, A., Coletti, R., Lehmann, C., Wanisch, A., Seidlmeier, A., et al. (2016). Dual-track clearance of circulating bacteria balances rapid restoration of blood sterility with induction of adaptive immunity. Cell Host Microbe 20, 36-48. doi: 10.1016/j.chom.2016.05.023
14. Brodeur, S. R., Angelini, F., Bacharier, L. B., Blom, A. M., Mizoguchi, E., Fujiwara, H., et al. (2003). C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18, 837-848. doi: 10.1016/S1074-7613(03)00149-3
15. Burman, J. D., Leung, E., Atkins, K. L., O'Seaghdha, M. N., Lango, L., Bernado, P., et al. (2008). Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein-Indications of a novel mechanism of complement evasion by Staphylococcus aureus. J. Biol. Chem. 283, 17579-17593. doi: 10.1074/jbc. M800265200
16. Callegaro-Filho, D., Shrestha, N., Burdick, A. E., and Haslett, P. A. J. (2010). A potential role for complement in immune evasion by Mycobacterium leprae. J. Drugs Dermatol. 9, 1373-1382.
17. Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., et al. (2010). Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862-871. doi: 10.1038/ni.1917
18. Carroll, M. C. (2004). The complement system in regulation of adaptive immunity. Nat. Immunol. 5, 981-986. doi: 10.1038/ni1113
19. Carroll, M. C., and Isenman, D. E. (2012). Regulation of humoral immunity by complement. Immunity 37, 199-207. doi: 10.1016/j.immuni.2012.08.002
20. Carter, R. H., and Fearon, D. T. (1992). CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107. doi: 10.1126/science.1373518
21. Carter, R. H., Spycher, M. O., Ng, Y. C., Hoffman, R., and Fearon, D. T. (1988). Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141, 457-463.
22. Cattaneo, R. (2004). Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78, 4385-4388. doi: 10.1128/JVI.78.9.4385-4388.2004
23. Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., et al. (1997). Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276, 960-964. doi: 10.1126/science.276.5314.960
24. Chen, A., Gaddipati, S., Hong, Y., Volkman, D. J., Peerschke, E. I., and Ghebrehiwet, B. (1994). Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J. Immunol. 153, 1430-1440.
25. Cherukuri, A., Cheng, P. C., and Pierce, S. K. (2001). The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167, 163-172. doi: 10.4049/jimmunol.167.1.163
26. Chung, K. M., Liszewski, M. K., Nybakken, G., Davis, A. E., Townsend, R. R., Fremont, D. H., et al. (2006). West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. U.S.A. 103, 19111-19116. doi: 10.1073/pnas.0605668103
27. Clarke, E. V., Weist, B. M., Walsh, C. M., and Tenner, A. J. (2015). Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J. Leukoc. Biol. 97, 147-160. doi: 10.1189/jlb.3A0614-278R
28. Cummings, K. L., Rosen, H. R., and Hahn, Y. S. (2009). Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin. Immunol. 132, 401-411. doi: 10.1016/j.clim.2009.05.002
29. Da Costa, X. J., Brockman, M. A., Alicot, E., Ma, M., Fischer, M. B., Zhou, X., et al. (1999). Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. U.S.A. 96, 12708-12712. doi: 10.1073/pnas.96.22.12708
30. Da Silva, R. P., Hall, B. F., Joiner, K. A., and Sacks, D. L. (1989). CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143, 617-622.
31. Dai, S., Rajaram, M. V. S., Curry, H. M., Leander, R., and Schlesinger, L. S. (2013). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9:e1003114. doi: 10.1371/journal.ppat.1003114
32. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C., and Fearon, D. T. (1996). C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350. doi: 10.1126/science.271.5247.348
33. Ellegård, R., Crisci, E., Burgener, A., Sjöwall, C., Birse, K., Westmacott, G., et al. (2014). Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J. Immunol. 193, 4590-4601. doi: 10.4049/jimmunol.1401781
34. 2 pathway. PLoS Pathog. 6:e1000975. doi: 10.1371/journal.ppat.1000975
35. Fischer, M. B. (1998). Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582-585. doi: 10.1126/science.280.5363.582
36. Frachet, P., Tacnet-Delorme, P., Gaboriaud, C., and Thielens, N. M. (2015). "Role of C1q in efferocytosis and self-tolerance-links with autoimmunity, "in Autoimmunity-Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases, ed. K. Chatzidionysiou (Rijeka: In Tech), doi: 10.5772/60519
37. Fries, L. F., Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Hammer, C. H., and Frank, M. M. (1986). Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J. Immunol. 137, 1636-1641.
38. Garcia, B. L., Zwarthoff, S. A., Rooijakkers, S. H. M., and Geisbrecht, B. V. (2016). Novel evasion mechanisms of the classical complement pathway. J. Immunol. 197, 2051-2060. doi: 10.4049/jimmunol.1600863
39. Girgis, N. M., DeHaven, B. C., Xiao, Y., Alexander, E., Viner, K. M., and Isaacs, S. N. (2011). The Vaccinia virus complement control protein modulates adaptive immune responses during infection. J. Virol. 85, 2547-2556. doi: 10.1128/JVI.01474-10
40. Hajishengallis, G., and Lambris, J. D. (2010). Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 31, 154-163. doi: 10.1016/j.it.2010.01.002
41. Hajishengallis, G., and Lambris, J. D. (2011). Microbial manipulation of receptor crosstalk in innate immunity. Nat. Rev. Immunol. 11, 187-200. doi: 10.1038/nri2918
42. Hajishengallis, G., and Lambris, J. D. (2016). More than complementing tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol. Rev. 274, 233-244. doi: 10.1111/imr.12467
43. Hajishengallis, G., Shakhatreh, M.-A. K., Wang, M., and Liang, S. (2007). Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol. 179, 2359-2367. doi: 10.4049/jimmunol.179.4.2359
44. Hammel, M., Sfyroera, G., Pyrpassopoulos, S., Ricklin, D., Ramyar, K. X., Pop, M., et al. (2007a). Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 282, 30051-30061. doi: 10.1074/jbc. M704247200
45. Hammel, M., Sfyroera, G., Ricklin, D., Magotti, P., Lambris, J. D., and Geisbrecht, B. V. (2007b). A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 8, 430-437. doi: 10.1038/ni1450
46. Heeger, P. S., Lalli, P. N., Lin, F., Valujskikh, A., Liu, J., Muqim, N., et al. (2005). Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201, 1523-1530. doi: 10.1084/jem.20041967
47. Heesters, B. A., Chatterjee, P., Kim, Y.-A., Gonzalez, S. F., Kuligowski, M. P., Kirchhausen, T., et al. (2013). Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity 38, 1164-1175. doi: 10.1016/j.immuni.2013.02.023
48. Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L., et al. (2006). CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915-927. doi: 10.1016/j.cell.2005.12.039
49. Holers, V. M. (2014). Complement and its receptors: new insights into human disease. Annu. Rev. Immunol. 32, 433-459. doi: 10.1146/annurev-immunol-032713-120154
50. Horakova, E., Gasser, O., Sadallah, S., Inal, J. M., Bourgeois, G., Ziekau, I., et al. (2004). Complement mediates the binding of HIV to erythrocytes. J. Immunol. 173, 4236-4241. doi: 10.4049/jimmunol.173.6.4236
51. Hosszu, K. K., Santiago-Schwarz, F., Peerschke, E. I. B., and Ghebrehiwet, B. (2010). Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun. 16, 115-127. doi: 10.1177/1753425909339815
52. Hosszu, K. K., Valentino, A., Vinayagasundaram, U., Vinayagasundaram, R., Joyce, M. G., Ji, Y., et al. (2012). DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood 120, 1228-1236. doi: 10.1182/blood-2011-07-369728
53. Isenman, D. E., Leung, E., Mackay, J. D., Bagby, S., and van den Elsen, J. M. H. (2010). Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure. J. Immunol. 184, 1946-1955. doi: 10.4049/jimmunol.0902919
54. Ishibashi, Y., Claus, S., and Relman, D. A. (1994). Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180, 1225-1233. doi: 10.1084/jem.180.4.1225
55. Jongerius, I., Kohl, J., Pandey, M. K., Ruyken, M., van Kessel, K. P. M., van Strijp, J. A. G., et al. (2007). Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204, 2461-2471. doi: 10.1084/jem.20070818
56. Jongerius, I., Puister, M., Wu, J., Ruyken, M., van Strijp, J. A. G., and Rooijakkers, S. H. M. (2010). Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases. J. Immunol. 184, 420-425. doi: 10.4049/jimmunol.0902865
57. Karp, C. L., Wysocka, M., Wahl, L. M., Ahearn, J. M., Cuomo, P. J., Sherry, B., et al. (1996). Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231. doi: 10.1126/science.273.5272.228
58. Kemper, C., and Atkinson, J. P. (2009). Measles virus and CD46. Curr. Top. Microbiol. Immunol. 329, 31-57. doi: 10.1007/978-3-540-70523-9_3
59. Kim, A. H. J., Dimitriou, I. D., Holland, M. C. H., Mastellos, D., Mueller, Y. M., Altman, J. D., et al. (2004). Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J. Immunol. 173, 2524-2529. doi: 10.4049/jimmunol.173.4.2524
60. Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., and Hahn, Y. S. (2000). Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106, 1239-1249. doi: 10.1172/JCI10323
61. Kolev, M., Dimeloe, S., Le Friec, G., Navarini, A., Arbore, G., Povoleri, G. A., et al. (2015). Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42, 1033-1047. doi: 10.1016/j.immuni.2015.05.024
62. Kolev, M., Le Friec, G., and Kemper, C. (2014). Complement-tapping into new sites and effector systems. Nat. Rev. Immunol. 14, 811-820. doi: 10.1038/nri3761
63. Kopf, M., Abel, B., Gallimore, A., Carroll, M., and Bachmann, M. F. (2002). Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8, 373-378. doi: 10.1038/nm0402-373
64. Korb, L. C., and Ahearn, J. M. (1997). C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.
65. Kostavasili, I., Sahu, A., Friedman, H. M., Eisenberg, R. J., Cohen, G. H., and Lambris, J. D. (1997). Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158, 1763-1771.
66. Koymans, K. J., Vrieling, M., Gorham, R. D., and van Strijp, J. A. G. (2016). Staphylococcal immune evasion proteins: structure, function, and host adaptation. Curr. Top. Microbiol. Immunol. doi: 10.1007/82_2015_5017 [Epub ahead of print].
67. Kwon, Y.-C., Kim, H., Meyer, K., Di Bisceglie, A. M., and Ray, R. (2016). Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by Hepatitis C virus. J. Immunol. 197, 1127-1136. doi: 10.4049/jimmunol.1600631
68. Lambris, J. D., Ricklin, D., and Geisbrecht, B. V. (2008). Complement evasion by human pathogens. Nat. Rev. Micro. 6, 132-142. doi: 10.1038/nrmicro1824
69. Le Friec, G., Sheppard, D., Whiteman, P., Karsten, C. M., Shamoun, S. A.-T., Laing, A., et al. (2012). The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat. Immunol. 13, 1213-1221. doi: 10.1038/ni.2454
70. Lee, L. Y. L., Höök, M., Haviland, D., Wetsel, R. A., Yonter, E. O., Syribeys, P., et al. (2004). Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190, 571-579. doi: 10.1086/422259
71. Li, K., Fazekasova, H., Wang, N., Peng, Q., Sacks, S. H., Lombardi, G., et al. (2012). Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 217, 65-73. doi: 10.1016/j.imbio.2011.07.033
72. Liang, S., Krauss, J. L., Domon, H., McIntosh, M. L., Hosur, K. B., Qu, H., et al. (2011). The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186, 869-877. doi: 10.4049/jimmunol.1003252
73. Liszewski, M. K., Kolev, M., Le Friec, G., Leung, M., Bertram, P. G., Fara, A. F., et al. (2013). Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 39, 1143-1157. doi: 10.1016/j.immuni.2013.10.018
74. López-Ribot, J. L., Martínez, J. P., and Chaffin, W. L. (1995). Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans. Infect. Immun. 63, 2126-2132.
75. Lubinski, J. M., Jiang, M., Hook, L., Chang, Y., Sarver, C., Mastellos, D., et al. (2002). Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J. Virol. 76, 9232-9241. doi: 10.1128/JVI.76.18.9232-9241.2002
76. Maekawa, T., Krauss, J. L., Abe, T., Jotwani, R., Triantafilou, M., Triantafilou, K., et al. (2014). Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15, 768-778. doi: 10.1016/j.chom.2014.05.012
77. Marie, J. C., Astier, A. L., Rivailler, P., Rabourdin-Combe, C., Wild, T. F., and Horvat, B. (2002). Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3, 659-666. doi: 10.1038/ni810
78. Marie, J. C., Kehren, J., Trescol-Biémont, M. C., Evlashev, A., Valentin, H., Walzer, T., et al. (2001). Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 14, 69-79. doi: 10.1016/S1074-7613(01)00090-5
79. Marth, T., and Kelsall, B. L. (1997). Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185, 1987-1995. doi: 10.1084/jem.185.11.1987
80. Matsumoto, A. K., Kopicky-Burd, J., Carter, R. H., Tuveson, D. A., Tedder, T. F., and Fearon, D. T. (1991). Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173, 55-64. doi: 10.1084/jem.173.1.55
81. Mazumdar, B., Kim, H., Meyer, K., Bose, S. K., Di Bisceglie, A. M., Ray, R. B., et al. (2012). Hepatitis C virus proteins inhibit C3 complement production. J. Virol. 86, 2221-2228. doi: 10.1128/JVI.06577-11
82. McGuirk, P., and Mills, K. H. (2000). Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur. J. Immunol 30, 415-422. doi: 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O
83. Mehlhop, E., and Diamond, M. S. (2006). Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203, 1371-1381. doi: 10.1084/jem.20052388
84. Mehlhop, E., Whitby, K., Oliphant, T., Marri, A., Engle, M., and Diamond, M. S. (2005). Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79, 7466-7477. doi: 10.1128/JVI.79.12.7466-7477.2005
85. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015a). Complement system part I-molecular mechanisms of activation and regulation. Front. Immunol. 6:262. doi: 10.3389/fimmu.2015.00262
86. Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015b). Complement system part II: role in immunity. Front. Immunol. 6:257. doi: 10.3389/fimmu.2015.00257
87. Montefiori, D. C., Cornell, R. J., Zhou, J. Y., Zhou, J. T., Hirsch, V. M., and Johnson, P. R. (1994). Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205, 82-92. doi: 10.1006/viro.1994.1622
88. Morgan, B. P., and Harris, C. L. (2015). Complement, a target for therapy in inflammatory and degenerative diseases. Nat. Rev. Drug. Discov. 14, 857-877. doi: 10.1038/nrd4657
89. Nayak, A., Pednekar, L., Reid, K. B., and Kishore, U. (2012). Complement and non-complement activating functions of C1q: a prototypical innate immune molecule. Innate Immun. 18, 350-363. doi: 10.1177/1753425910396252
90. Nguyen, T., Ghebrehiwet, B., and Peerschke, E. I. (2000). Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 68, 2061-2068. doi: 10.1128/IAI.68.4.2061-2068.2000
91. Ojha, H., Panwar, H. S., Gorham, R. D., Morikis, D., and Sahu, A. (2014). Viral regulators of complement activation: structure, function and evolution. Mol. Immunol. 61, 89-99. doi: 10.1016/j.molimm.2014.06.004
92. Oliva, C., Turnbough, C. L., and Kearney, J. F. (2009). CD14-Mac-1 interactions in Bacillus anthracis spore internalization by macrophages. Proc. Natl. Acad. Sci. U.S.A. 106, 13957-13962. doi: 10.1073/pnas.0902392106
93. Oliva, C. R., Swiecki, M. K., Griguer, C. E., Lisanby, M. W., Bullard, D. C., Turnbough, C. L., et al. (2008). The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl. Acad. Sci. U.S.A. 105, 1261-1266. doi: 10.1073/pnas.0709321105
94. Olivar, R., Luque, A., Cárdenas-Brito, S., Naranjo-Gómez, M., Blom, A. M., Borràs, F. E., et al. (2016). The complement inhibitor factor H generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells. J. Immunol. 196, 4274-4290. doi: 10.4049/jimmunol.1500455
95. Olivar, R., Luque, A., Naranjo-Gómez, M., Quer, J., García de Frutos, P., Borràs, F. E., et al. (2013). The α7β0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells. J. Immunol. 190, 2857-2872. doi: 10.4049/jimmunol.1200503
96. Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., et al. (2008). Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 111, 2452-2461. doi: 10.1182/blood-2007-06-095018
97. Potempa, M., and Potempa, J. (2012). Protease-dependent mechanisms of complement evasion by bacterial pathogens. Biol. Chem. 393, 873-888. doi: 10.1515/hsz-2012-0174
98. Price, J. D., Schaumburg, J., Sandin, C., Atkinson, J. P., Lindahl, G., and Kemper, C. (2005). Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 175, 677-684. doi: 10.4049/jimmunol.175.2.677
99. Rickert, R. C. (2005). Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17, 237-243. doi: 10.1016/j.coi.2005.03.001
100. Ricklin, D. (2012). Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy. Immunobiology 217, 1057-1066. doi: 10.1016/j.imbio.2012.07.016
101. Ricklin, D., and Lambris, J. D. (2013). Complement in immune and inflammatory disorders: therapeutic interventions. J. Immunol. 190, 3839-3847. doi: 10.4049/jimmunol.1203200
102. Ricklin, D., Ricklin-Lichtsteiner, S. K., Markiewski, M. M., Geisbrecht, B. V., and Lambris, J. D. (2008). Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J. Immunol. 181, 7463-7467. doi: 10.4049/jimmunol.181.11.7463
103. Sacks, S. H., and Zhou, W. (2012). The role of complement in the early immune response to transplantation. Nat. Rev. Immunol. 12, 431-442. doi: 10.1038/nri3225
104. Schifferli, J. A., Ng, Y. C., Estreicher, J., and Walport, M. J. (1988). The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement-and erythrocyte complement receptor 1-dependent mechanisms. J. Immunol. 140, 899-904.
105. Sontheimer, R. D., Racila, E., and Racila, D. M. (2005). C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J. Invest. Dermatol. 125, 14-23. doi: 10.1111/j.0022-202X.2005.23673.x
106. Stoermer, K. A., and Morrison, T. E. (2011). Complement and viral pathogenesis. Virology 411, 362-373. doi: 10.1016/j.virol.2010.12.045
107. Stoiber, H., Banki, Z., Wilflingseder, D., and Dierich, M. P. (2008). Complement-HIV interactions during all steps of viral pathogenesis. Vaccine 26, 3046-3054. doi: 10.1016/j.vaccine.2007.12.003
108. Stoiber, H., Ebenbichler, C., Schneider, R., Janatova, J., and Dierich, M. P. (1995). Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 9, 19-26. doi: 10.1097/00002030-199501000-00003
109. Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., et al. (2008). Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28, 425-435. doi: 10.1016/j.immuni.2008.02.001
110. Strainic, M. G., Shevach, E. M., An, F., Lin, F., and Medof, M. E. (2012). Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells. Nat. Immunol. 14, 162-171. doi: 10.1038/ni.2499
111. Stringaro, A., Crateri, P., Adriani, D., Arancia, G., Cassone, A., Calderone, R. A., et al. (1998). Expression of the complement-binding protein (MP60) of Candida albicans in experimental vaginitis. Mycopathologia 144, 147-152. doi: 10.1023/A:1007017012547
112. Sullivan, B. L., Takefman, D. M., and Spear, G. T. (1998). Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism. Virology 248, 173-181. doi: 10.1006/viro.1998.9289
113. Suthar, M. S., Diamond, M. S., and Gale, M. Jr. (2013). West Nile virus infection and immunity. Nat. Rev. Micro. 11, 115-128. doi: 10.1038/nrmicro2950
114. Tabouret, G., Astarie-Dequeker, C., Demangel, C., Malaga, W., Constant, P., Ray, A., et al. (2010). Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog. 6:e1001159. doi: 10.1371/journal.ppat.1001159
115. Tam, J. C. H., Bidgood, S. R., McEwan, W. A., and James, L. C. (2014). Intracellular sensing of complement C3 activates cell autonomous immunity. Science 345, 1256070-1256070. doi: 10.1126/science.1256070
116. Teh, B. K., Yeo, J. G., Chern, L. M., and Lu, J. (2011). C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol. Immunol. 48, 1128-1138. doi: 10.1016/j.molimm.2011.02.006
117. Thammavongsa, V., Kim, H. K., Missiakas, D., and Schneewind, O. (2015). Staphylococcal manipulation of host immune responses. Nat. Rev. Micro. 13, 529-543. doi: 10.1038/nrmicro3521
118. Toapanta, F. R., and Ross, T. M. (2006). Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol. Res. 36, 197-210. doi: 10.1385/IR:36:1:197
119. Waggoner, S. N., Cruise, M. W., Kassel, R., and Hahn, Y. S. (2005). gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175, 4706-4714. doi: 10.4049/jimmunol.175.7.4706
120. Waggoner, S. N., Hall, C. H. T., and Hahn, Y. S. (2007). HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J. Leukoc. Biol. 82, 1407-1419. doi: 10.1189/jlb.0507268
121. Wang, M., Krauss, J. L., Domon, H., Hosur, K. B., Liang, S., Magotti, P., et al. (2010). Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 3, ra11-ra11. doi: 10.1126/scisignal.2000697
122. Wang, M., Shakhatreh, M.-A. K., James, D., Liang, S., Nishiyama, S.-I., Yoshimura, F., et al. (2007). Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 179, 2349-2358. doi: 10.4049/jimmunol.179.4.2349
123. Wang, R. Y., Bare, P., De Giorgi, V., Matsuura, K., Salam, K. A., Grandinetti, T., et al. (2016). Preferential association of hepatitis C virus with CD19(+) B cells is mediated by complement system. Hepatology 64, 1900-1910. doi: 10.1002/hep.28842
124. Weaver, D. J., Reis, E. S., Pandey, M. K., Köhl, G., Harris, N., Gerard, C., et al. (2010). C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur. J. Immunol. 40, 710-721. doi: 10.1002/eji.200939333
125. Williams, K. T., Young, S. P., Negus, A., Young, L. S., Adams, D. H., and Afford, S. C. (2007). C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival. PLoS ONE 2:e159. doi: 10.1371/journal.pone.0000159
126. Yanagi, Y., Takeda, M., and Ohno, S. (2006). Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol. 87, 2767-2779. doi: 10.1099/vir.0.82221-0
127. Yao, Z. Q., Nguyen, D. T., Hiotellis, A. I., and Hahn, Y. S. (2001a). Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167, 5264-5272. doi: 10.4049/jimmunol.167.9.5264
128. Yao, Z. Q., Ray, S., Eisen-Vandervelde, A., Waggoner, S., and Hahn, Y. S. (2001b). Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol. 14, 277-295. doi: 10.1089/08828240152716547
129. Zhang, J., Li, G., Liu, X., Wang, Z., Liu, W., and Ye, X. (2009). Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J. Gen. Virol. 90, 2751-2758. doi: 10.1099/vir.0.014316-0
130. Zipfel, P. F., Hallström, T., and Riesbeck, K. (2013). Human complement control and complement evasion by pathogenic microbes-tipping the balance. Mol. Immunol. 56, 152-160. doi: 10.1016/j.molimm.2013.05.222